Drug Profile


Alternative Names: Anadrol-50; CI 406

Latest Information Update: 27 Feb 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Unimed Pharmaceuticals
  • Class Androstanols; Antianaemics; Small molecules
  • Mechanism of Action Protein synthesis stimulants; Stem cell stimulants; Testosterone congener stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Anaemia
  • Discontinued Cachexia

Most Recent Events

  • 23 Feb 2001 A study has been added to the Metabolic Disorders therapeutic trials section
  • 14 Jul 1998 Investigation in Cachexia in USA (PO)
  • 14 Jul 1998 Launched for Anaemia in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top